Journal
GENES
Volume 4, Issue 3, Pages 435-456Publisher
MDPI
DOI: 10.3390/genes4030435
Keywords
brain; siRNA; RNAi; traumatic brain injury; stroke; ischemia; subarachnoid hemorrhage
Categories
Funding
- National Institute of Health [NINDS R01HD061946]
Ask authors/readers for more resources
Ever since the discovery of small interfering ribonucleic acid (siRNA) a little over a decade ago, it has been highly sought after for its potential as a therapeutic agent for many diseases. In this review, we discuss the promising possibility of siRNA to be used as a drug to treat acute brain injuries such as stroke and traumatic brain injury. First, we will give a brief and basic overview of the principle of RNA interference as an effective mechanism to decrease specific protein expression. Then, we will review recent in vivo studies describing siRNA research experiments/treatment options for acute brain diseases. Lastly, we will discuss the future of siRNA as a clinical therapeutic strategy against brain diseases and injuries, while addressing the current obstacles to effective brain delivery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available